Poisson statistics estimate the probability that a well receives zero, one, or multiple cells when a diluted suspension is distributed across wells. Targeting an average occupancy below one cell per well increases the likelihood of isolated-cell wells, but it does not guarantee single-cell occupancy. These estimates therefore guide dilution choices and help interpret the resulting colonies.
Low density reduces the chance that multiple starting cells enter the same well and later form a mixed colony. When an isolated cell expands, its descendants can be evaluated as a candidate clone with greater genetic or phenotypic uniformity. The approach is especially useful when consistent cell behavior or biological material is required.
A colony from a low-occupancy well is not automatically proven clonal because the well may have received more than one cell. Limiting dilution lowers that probability rather than eliminating it. Follow-up verification is therefore important when researchers need to validate a stable phenotype, genetic uniformity, or a reliable source of consistent biological material.
The process begins with a cell suspension from a mixed population, followed by serial dilution to reduce the number of cells delivered to each well. The diluted suspension is then distributed across wells at low density, often aiming for an average of less than one cell per well. Wells containing growing colonies can subsequently be selected for analysis.
Researchers can select colonies that arise from isolated-cell wells and expand them as candidate cell lines. Comparing their behavior or phenotype helps identify populations with the desired stable characteristics. This workflow supports clonal cell-line development and genetic screening, while subsequent clonality checks strengthen confidence that the selected line originated from a single cell.
Limiting dilution cloning can separate individual cells from a mixed population so that selected descendants can be expanded and evaluated for consistent properties. In hybridoma research, this supports the development of clonal populations used for monoclonal antibody production. The same strategy also helps validate that the biological material comes from a population with the intended stable phenotype.